Warren Buffett is frequently called the "Oracle of Omaha." An oracle, by definition, is something that provides wise counsel and often foretells the future. Buffett's uncanny ability to pick stocks that beat the market over the long term seems to justify his nickname.

So when the Oracle of Omaha sells a specific group of stocks pretty much across the board, it raises eyebrows. And that's just what he has done over the past several quarters. Do Buffett's recent moves spell doom for pharma stocks?

Image source: The Motley Fool.

Continue reading

Source Fool.com